Browse News
Filter News
Found 18,787 articles
-
Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs.
-
BioSpace spoke to analysts and players in the contract manufacturing and development organizations space to assess the challenges this year and what lies ahead in 2024.
-
GE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023
11/29/2023
Through its leading imaging solutions and commitment to innovation, GE HealthCare remains at the forefront of leveraging deep learning, a subset of artificial intelligence, to benefit a multitude of clinicians and patients.
-
Drug Discovery Services Market Size To Hold USD 75.68 Bn By 2032
11/29/2023
The global drug discovery services market size was exhibited at USD 19.37 billion in 2022 and it is expected to hit around USD 75.68 billion by 2032, growing at a CAGR of 14.6% during the forecast period from 2023 to 2032.
-
Keep up with the regulator’s latest rulings on novel drugs and expanded indications, as the second half of 2023 promises some major milestone FDA approvals.
-
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
11/28/2023
Centogene N.V. announced that it has completed the transaction to form a new joint venture with Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund.
-
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
11/28/2023
BioReference® Health, LLC, a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data for the pharmaceutical and life science industries.
-
iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare
11/28/2023
iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced that key artificial intelligence (AI) powered solutions from iCAD’s ProFound Breast Health Suite are the first applications to be offered in GE HealthCare’s new MyBreastAI Suite* offering.
-
Nanox Announces Third Quarter of 2023 Financial Results and Provides Business Update
11/28/2023
NANO-X IMAGING LTD today announced results for the third quarter ended September 30, 2023 and provided a business update.
-
BioMarin Announces Agreement with German Health Insurance Fund on Reimbursement Amount for ROCTAVIAN® (valoctocogene roxaparvovec-rvox) for Severe Hemophilia A in Germany
11/28/2023
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced an agreement with the German National Association of Statutory Health Insurance Funds (GKV-SV) on the reimbursement amount for ROCTAVIAN® (valoctocogene roxaparvovec-rvox) for people with severe hemophilia A.
-
GE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis
11/28/2023
Today GE HealthCare (Nasdaq: GEHC) announced an industry-first US FDA 510K clearance of Critical Care Suite 2.1 featuring a Pneumothorax (PTX) algorithm for the detection, notification, triage and diagnosis of PTX.
-
Gene Bio Medical (GBM): Leading the Charge in Biotechnological Innovation and Global Healthcare Revolution
11/28/2023
In a remarkable year of breakthroughs and strategic advancements, Gene Bio Medical, a promising venture in the Canadian biotechnology landscape, has solidified its position as a pioneer in healthcare innovation.
-
Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis
11/28/2023
Quest Diagnostics and Scipher Medicine, today announced a multi-pronged collaboration designed to expand patient access to diagnostic services advancing precision medicine for rheumatoid arthritis (RA).
-
Bayer and Hurdle launch precision health strategic partnership
11/28/2023
Hurdle, a pioneer in diagnostic testing, and the Consumer Health division of Bayer have launched a strategic partnership to advance consumer innovations in the emerging area of healthy aging.
-
GE HealthCare Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection
11/27/2023
GE HealthCare announced the release of a new, all-in-one platform of artificial intelligence apps to support clinicians with breast cancer detection and improved workflow productivity called MyBreastAI Suite*.
-
Philips launches HealthSuite Imaging, a cloud-based next generation of Vue PACS, with new AI-enabled clinical and operational workflows at #RSNA23
11/27/2023
Royal Philips, a global leader in health technology, announced the expansion of its enterprise imaging portfolio and AI-enabled solutions at #RSNA23.
-
AI in Cancer Diagnostics Market Expected to Reach USD 2,084.34 Million by 2032
11/27/2023
The AI in cancer diagnostics market is estimated to reach around USD 2,084.34 million by 2032 to grow from USD 892.23 million in 2022, growing at a remarkable CAGR of 9.35% between 2023 and 2032.
-
Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID
11/27/2023
Revvity, Inc., announced the launch of its EONIS™ Q system, a CE-IVD declared platform enabling laboratories in countries that accept the CE marking to adopt molecular testing for spinal muscular atrophy and severe combined immunodeficiency in newborns.
-
Takeda to Present Data at 65th American Society of Hematology (ASH) Annual Meeting, Demonstrating Continued Commitment to Patients with Hematologic Diseases
11/27/2023
Takeda to Present Data at 65th American Society of Hematology (ASH) Annual Meeting, Demonstrating Continued Commitment to Patients with Hematologic Diseases.
-
Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
11/27/2023
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), today announced financial results and provided a corporate update for the third quarter and nine months ended September 30, 2023.